Dr. Rajendra Pangeni, completed his PhD in molecular oncology from the University of Wolverhampton, UK. During his PhD, he worked on DNA methylation dysregulation in breast cancer metastases to the brain using genome wide and laboratory approaches. He received his post-doctoral trainings from Northwestern University Chicago and City of Hope National Medical Center, Duarte, California. During his post doctoral works, Dr. Pangeni worked on glioblastoma (one of the most aggressive brain tumors) and non-small cell lung cancer using genome wide DNA methylation array, RNA sequencing, stem cells, mouse models, and other genetic and epigenetics approaches.
At Nova Southeastern University, Dr. Pangeni is working on identifying genes that could be used as potential biomarkers and therapeutic targets in Gulf War illness, chronic fatigue syndrome (CFS), cancer and other genetic/epigenetic diseases. He uses single cell transcriptomics, whole-genome bisulfite sequencing, and other state-of-the-art technologies and laboratory approaches.
Cancer and metastases, stem cells, Gulf war Illness, Chronic Fatigue Syndrome (CFS), Biomarkers, Experimental therapeutics, genomics and epigenomics.
For complete list of Publications, visit: